Literature DB >> 30277274

3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo.

Zhongxu An1, Vivek Tiwari1, Jeannie Baxter1, Michael Levy2, Kimmo J Hatanpaa3, Edward Pan2,4,5, Elizabeth A Maher4,5,6,7, Toral R Patel2,4, Bruce E Mickey2,5,7, Changho Choi1,5,8.   

Abstract

PURPOSE: To develop 3D high-resolution imaging of 2-hydroxyglutarate (2HG) at 3T in vivo.
METHODS: Echo-planar spectroscopic imaging with dual-readout alternated-gradients (DRAG-EPSI), which was recently reported for 2D imaging of 2HG at 7T, was tested for 3D imaging of 2HG at 3T. The frequency drifts and acoustic noise induced by DRAG-EPSI were investigated in comparison with conventional EPSI. Four patients with IDH-mutant gliomas were enrolled for 3D imaging of 2HG and other metabolites. A previously reported 2HG-tailored TE 97-ms PRESS sequence preceded the DRAG-EPSI readout gradients. Unsuppressed water, acquired with EPSI, was used as reference for multi-channel combination, eddy-current compensation, and metabolite quantification. Spectral fitting was conducted with the LCModel using in-house basis sets.
RESULTS: With gradient strength of 4 mT/m and slew rate of 20 mT/m/ms, DRAG-EPSI produced frequency drifts smaller by 5.5-fold and acoustic noise lower by 25 dB compared to conventional EPSI. In a 19-min scan, 3D DRAG-EPSI provided images of 2HG with precision (CRLB <10%) at a resolution of 10 × 10 × 10 mm3 for a field of view of 240 × 180 × 80 mm3 . 2HG was estimated to be 5 mM in a pre-treatment patient. In 3 post-surgery patients, 2HG estimates were 3-6 mM, and the 2HG distribution was different from the water-T2 image pattern or highly concentrated in the post-contrast enhancing region.
CONCLUSION: Together with 2HG-optimized PRESS, DRAG-EPSI provides an effective tool for reliable 3D high-resolution imaging of 2HG at 3T in vivo.
© 2018 The Authors Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  1H MRS; 2-hydroxyglutarate (2HG); 3T; dual-readout alternated-gradients EPSI (DRAG-EPSI); echo-planar spectroscopy imaging (EPSI); glioma; human brain tumor

Mesh:

Substances:

Year:  2018        PMID: 30277274      PMCID: PMC6289635          DOI: 10.1002/mrm.27482

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  20 in total

1.  Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy.

Authors:  Andreas Ebel; Andrew A Maudsley
Journal:  Magn Reson Imaging       Date:  2003-02       Impact factor: 2.546

2.  Detection and correction of frequency instabilities for volumetric 1H echo-planar spectroscopic imaging.

Authors:  Andreas Ebel; Andrew A Maudsley
Journal:  Magn Reson Med       Date:  2005-02       Impact factor: 4.668

3.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T.

Authors:  Ralf Mekle; Vladimír Mlynárik; Giulio Gambarota; Martin Hergt; Gunnar Krueger; Rolf Gruetter
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

4.  Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.

Authors:  Changho Choi; Jack M Raisanen; Sandeep K Ganji; Song Zhang; Sarah S McNeil; Zhongxu An; Akshay Madan; Kimmo J Hatanpaa; Vamsidhara Vemireddy; Christie A Sheppard; Dwight Oliver; Keith M Hulsey; Vivek Tiwari; Tomoyuki Mashimo; James Battiste; Samuel Barnett; Christopher J Madden; Toral R Patel; Edward Pan; Craig R Malloy; Bruce E Mickey; Robert M Bachoo; Elizabeth A Maher
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

5.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T.

Authors:  Ivan Tkác; Gülin Oz; Gregor Adriany; Kamil Uğurbil; Rolf Gruetter
Journal:  Magn Reson Med       Date:  2009-10       Impact factor: 4.668

6.  Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.

Authors:  Kourosh Jafari-Khouzani; Franziska Loebel; Wolfgang Bogner; Otto Rapalino; Gilberto R Gonzalez; Elizabeth Gerstner; Andrew S Chi; Tracy T Batchelor; Bruce R Rosen; Jan Unkelbach; Helen A Shih; Daniel P Cahill; Ovidiu C Andronesi
Journal:  Neuro Oncol       Date:  2016-07-05       Impact factor: 12.300

7.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

8.  (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.

Authors:  Matthew L Zierhut; Esin Ozturk-Isik; Albert P Chen; Ilwoo Park; Daniel B Vigneron; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2009-09       Impact factor: 4.813

9.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

10.  2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.

Authors:  Changho Choi; Sandeep K Ganji; Ralph J DeBerardinis; Kimmo J Hatanpaa; Dinesh Rakheja; Zoltan Kovacs; Xiao-Li Yang; Tomoyuki Mashimo; Jack M Raisanen; Isaac Marin-Valencia; Juan M Pascual; Christopher J Madden; Bruce E Mickey; Craig R Malloy; Robert M Bachoo; Elizabeth A Maher
Journal:  Nat Med       Date:  2012-01-26       Impact factor: 53.440

View more
  7 in total

Review 1.  Application of 7T MRS to High-Grade Gliomas.

Authors:  L McCarthy; G Verma; G Hangel; A Neal; B A Moffat; J P Stockmann; O C Andronesi; P Balchandani; C G Hadjipanayis
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

2.  Spectral fitting strategy to overcome the overlap between 2-hydroxyglutarate and lipid resonances at 2.25 ppm.

Authors:  Pegah Askari; Ivan E Dimitrov; Sandeep K Ganji; Vivek Tiwari; Michael Levy; Toral R Patel; Edward Pan; Bruce E Mickey; Craig R Malloy; Elizabeth A Maher; Changho Choi
Journal:  Magn Reson Med       Date:  2021-05-12       Impact factor: 3.737

3.  Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B0 -shim array coils at 3 T.

Authors:  Bernhard Strasser; Nicolas S Arango; Jason P Stockmann; Borjan Gagoski; Bijaya Thapa; Xianqi Li; Wolfgang Bogner; Philipp Moser; Julia Small; Daniel P Cahill; Tracy T Batchelor; Jorg Dietrich; Andre van der Kouwe; Jacob White; Elfar Adalsteinsson; Ovidiu C Andronesi
Journal:  NMR Biomed       Date:  2021-10-05       Impact factor: 4.478

Review 4.  2-Hydroxyglutarate in Cancer Cells.

Authors:  Petr Ježek
Journal:  Antioxid Redox Signal       Date:  2020-01-22       Impact factor: 7.468

5.  The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.

Authors:  Feng-Min Liu; Yu-Fei Gao; Yanyan Kong; Yihui Guan; Jinsen Zhang; Shuai-Hong Li; Dan Ye; Wenyu Wen; Chuantao Zuo; Wei Hua
Journal:  BMC Cancer       Date:  2021-01-20       Impact factor: 4.430

6.  Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Authors:  Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher
Journal:  NMR Biomed       Date:  2020-04-29       Impact factor: 4.044

7.  Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

Authors:  Xianqi Li; Bernhard Strasser; Kourosh Jafari-Khouzani; Bijaya Thapa; Julia Small; Daniel P Cahill; Jorg Dietrich; Tracy T Batchelor; Ovidiu C Andronesi
Journal:  Radiology       Date:  2020-01-07       Impact factor: 29.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.